# 2025-21456: Medicare 2027 Shake-Up: New Rules for Advantage, Drugs, and Plans

2025-21456, Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program, is a Federal Register proposed rule from Health and Human Services Department, Centers for Medicare & Medicaid Services published 2025-11-28, effective 2026-10-01; deemed significant under Executive Order 12866; PRIA reads it as touching household money (as of 2026-11-17).

- Canonical: https://policyrisk.com/federal-register/2025-21456
- As of: 2026-11-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21456
- Title: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program
- Type: Proposed Rule
- Agencies: Health and Human Services Department; Centers for Medicare & Medicaid Services
- Citation: 90 FR 54894
- Published: 2025-11-28
- Effective: 2026-10-01
- Comments close: not stated
- Significant: yes (OIRA_API)
- Touches household money: yes
- Regulation identifier numbers: 0938-AV63
- Last updated: 2026-11-17

## In one line

Medicare 2027 Shake-Up: New Rules for Advantage, Drugs, and Plans

## Summary

Starting in 2027, Medicare Advantage, Prescription Drug, and Cost Plan programs will see updates to improve how plans are rated, marketed, and how drugs are covered. These changes affect millions of Medicare users and the companies that run these plans, aiming to make enrollment easier and benefits clearer. Comments on these updates are open until January 26, 2026, so stakeholders can weigh in before the new rules take effect.

## Abstract

This proposed rule would revise the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), and Medicare cost plan regulations to implement changes related to Star Ratings, marketing and communications, drug coverage, enrollment processes, special needs plans, and other programmatic areas.

## Effects PRIA read

- Part D redesign: $2,000 OOP and three phases: benefit, high. Medicare Part D is being changed to a three-phase benefit: deductible, initial coverage (25% coinsurance), and catastrophic with $0 cost sharing. The annual out-of-pocket (OOP) threshold was set at $2,000 for 2025 and was $2,100 for 2026; for 2026 and later years the OOP threshold will increase eac…
- No deductible for vaccines and capped insulin cost: benefit, medium. The Part D deductible does not apply to ACIP-recommended adult vaccines and covered insulin products. For 2023–2025, the one-month cost-sharing amount for covered insulin products was $35; for 2026 and subsequent years the applicable cost-sharing amount for a one-month supply of covered insulin is…
- Manufacturer Discount Program replaces Coverage Gap: benefit, medium. The rule would codify the Manufacturer Discount Program, which replaced the Coverage Gap Discount Program and began on January 1, 2025. Under the Manufacturer Discount Program, manufacturers that enter agreements are required to provide discounts on applicable drugs in both the initial and catastro…
- Changes to TrOOP, reinsurance, and Selected Drug rules: mixed, low. The proposed rule would codify updates to what payments count as True Out-Of-Pocket (TrOOP), establish how costs for drugs not subject to the Part D deductible count toward eligibility for manufacturer discounts under the Manufacturer Discount Program, and update the methodology for CMS reinsurance…
- Simplifying Star Ratings; no Health Equity reward: mixed, low. CMS proposes changes to simplify and refocus the Star Ratings measure set, proposes not to implement the Health Equity Index (also called Excellent Health Outcomes for All) reward, and would continue to include the historical reward factor in the Star Ratings methodology. CMS is soliciting comments…
- Marketing and agent rules changing Oct 1, 2026: mixed, medium. CMS proposes revisions to marketing and communications rules applicable to contract year 2027 marketing beginning October 1, 2026. Proposed changes include modifying the definition and oversight of third-party marketing organizations (TPMOs), changing the 5 percent translation requirement, removing…

## Related documents

- [2026-22792](https://policyrisk.com/federal-register/2026-22792): Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, 2026-11-09
- [2026-22750](https://policyrisk.com/federal-register/2026-22750): Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the E…, 2026-11-09
- [2026-22743](https://policyrisk.com/federal-register/2026-22743): Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage…, 2026-11-09
- [2026-22739](https://policyrisk.com/federal-register/2026-22739): Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; i…, 2026-11-06
- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03
- [2026-22194](https://policyrisk.com/federal-register/2026-22194): Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Paym…, 2026-10-30

## Sources
- [2025-21456 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/28/2025-21456/medicare-program-contract-year-2027-policy-and-technical-changes-to-the-medicare-advantage-program)
- [2025-21456 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-28/pdf/2025-21456.pdf)

## Related
- [Previous: 2025-21437, Airworthiness Directives; Airbus Helicopters](https://policyrisk.com/federal-register/2025-21437)
- [Next: 2025-21495, Airworthiness Directives; Airbus Helicopters](https://policyrisk.com/federal-register/2025-21495)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21456 (as of 2026-11-17).
